Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
Submitted by
admin
on October 17, 2016 - 11:46pm
Source:
Endpoints
News Tags:
PTC Therapeutics
FDA
Duchenne Muscular Dystrophy
Translarna
Headline:
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
Do Not Allow Advertisers to Use My Personal information
